You do not currently have permission to view the full text for this document. Please sign in to an account with an active subscription or contact support.
The increasing prevalence of gender dysphoria or transgender identity in children and adolescents has raised clinical, ethical and psychological concerns, particularly regarding the efficacy and appropriateness of medical interventions. This paper explores the critical role of thorough psychological assessment in addressing gender dysphoria, with a focus on the closure of the Tavistock NHS Gender Identity Service (GIDS) and the findings of the Cass Review. The author draws on her clinical experience to argue for a comprehensive, individualized approach to the treatment of children and young adults with gender identity conflicts. Key issues discussed include the lack of a robust evidence base for early medical treatments, such as puberty blockers and cross-sex hormones, and the ethical implications of medicalising the bodies of children before psychological and physical maturity. The paper argues that many children presenting with gender confusion may be navigating complex psychological conflicts, including issues of identity, sexual orientation, anxiety and trauma, and that rushing into potentially harmful and life-changing medical treatments may remove opportunities for addressing these emotional struggles. The author critiques the affirmative model of treatment, advocating for a more cautious, holistic and empathetic framework that prioritises improved assessment, psychological support and the time required between early adolescent pubertal changes and full sexual, psychological maturation. The paper highlights the implications of the Bell v. Tavistock Judicial Review and questions the issue of informed consent to hormone treatments. The author calls for the restoration of ethical clinical practices aiming to reduce potential harm and improve long-term outcomes.